Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MITF | O75030 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5447641 | 1.00 | ALDH1A1 (0.56) | ALDH1A1HPGDLMNACYP19A1CA1 | |
| SCHEMBL31290120 | 1.00 | ALDH1A1 (0.56) | ALDH1A1HPGDLMNACYP19A1CA1 | |
| SCHEMBL19020461 | 1.00 | ALDH1A1 (0.56) | ALDH1A1HPGDLMNACYP19A1CA1 | |
| SCHEMBL21331621 | 1.00 | ALDH1A1 (0.56) | ALDH1A1HPGDLMNACYP19A1CA1 | |
| SCHEMBL18585887 | 0.89 | ALDH1A1 (0.49) | ALDH1A1HPGDLMNACYP19A1CA1 | |
| SCHEMBL31088265 | 0.89 | ALDH1A1 (0.46) | ALDH1A1HPGDLMNACYP19A1CA1 | |
| SCHEMBL28040137 | 0.88 | TRPM8 (0.51) | ALDH1A1HPGDLMNACYP19A1NPSR1 | |
| SCHEMBL28040136 | 0.88 | TRPM8 (0.51) | ALDH1A1HPGDLMNACYP19A1NPSR1 | |
| SCHEMBL14708959 | 0.87 | CYP19A1 (0.52) | ALDH1A1HPGDLMNACYP19A1NPSR1 | |
| SCHEMBL5085130 | 0.85 | ALDH1A1 (0.56) | ALDH1A1HPGDLMNACYP19A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118205269-B | Cold-feeling breathable antibacterial fabric containing nylon fibers and preparation method thereof | 汕头市和辉实业有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-118205269-A | Cold-feeling breathable antibacterial fabric containing nylon fibers and preparation method thereof | 汕头市和辉实业有限公司 | 2024-06-18 | — | — | CN | claimed |
| EP-4731727-A1 | HALF-WAVE PLATE | Merck Patent GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4713413-A1 | CHIRAL REACTIVE MESOGEN MIXTURE | Merck Patent GmbH (DE) | 2026-03-25 | — | — | EP | disclosed |
| CN-121586757-A | Half wave plate | 默克专利股份有限公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-119269665-A | Method for detecting menthol content based on rapid and catalyst-free pre-column derivative liquid chromatography | 广东超聚和生物科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-119184087-A | Application of cinnamic acid terpene ester derivatives in prevention and treatment of bacterial wilt | 南京中医药大学翰林学院 | 2024-12-27 | — | — | CN | disclosed |
| CN-119184087-A | Application of cinnamic acid terpene ester derivatives in prevention and treatment of bacterial wilt | 南京中医药大学翰林学院 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024260930-A1 | HALF-WAVE PLATE | MERCK PATENT GMBH (DE) | 2024-12-26 | — | — | WO | disclosed |
| WO-2024235947-A1 | CHIRAL REACTIVE MESOGEN MIXTURE | MERCK PATENT GMBH (DE) | 2024-11-21 | — | — | WO | disclosed |
| CN-118205269-B | Cold-feeling breathable antibacterial fabric containing nylon fibers and preparation method thereof | 汕头市和辉实业有限公司 | 2024-07-09 | — | — | CN | disclosed |
| EP-3464241-B1 | NEW MENTHYL NICOTINATE SYNTHESIS PROCESS | MULTICHEM R&D S R L (IT) | 2020-06-10 | — | — | EP | disclosed |
| US-9730875-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2017-08-15 | — | — | US | disclosed |
| US-9458081-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| EP-2881107-B1 | Compositions and method for the stimulation of the female and male sexual response | MULTICHEM R&D S R L (IT) | 2016-09-07 | — | — | EP | disclosed |
| US-20160143829-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA | 2016-05-26 | — | — | US | disclosed |
| US-9284261-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-03-15 | — | — | US | disclosed |
| EP-2881107-A1 | Compositions and method for the stimulation of the female and male sexual response | Multichem S.A.S. di Gabriele Segalla (IT) | 2015-06-10 | — | — | EP | disclosed |
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | ALDH1A1 236/4885HPGD 774/4885LMNA 1058/4885 |
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | ALDH1A1 234/4885HPGD 656/4885LMNA 1414/4885 |
| US-20160143829-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | ALDH1A1 234/4885HPGD 656/4885LMNA 1414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.